Reliability of Spanish translations of select urological quality of life instruments. Commentary.
Many patients with urological disease do not speak English.
In medical studies restricting patients to those who speak only English undermines efforts to understand disease because restrictions decrease efficiency of patient recruitment, and because language and culture are associated with variable outcomes.
In Spanish speaking locations, such as South Florida, studies would suffer severe selection bias if patients were required to speak English.
To allow grouping in future studies of English and Spanish speaking patients we examined the English-Spanish reliability of select instruments that measure health related quality of life in patients with urological disease.
Materials and Methods
We assembled available Spanish versions and translated English versions of questions regarding satisfaction, the American Urological Association symptom index, the University of California, Los Angeles Prostate Cancer Index and a pain inventory.
We then examined English-Spanish reliability by asking bilingual men 50 years old or older to complete English and Spanish versions at the same sitting.
A convenience sample was recruited from outpatients and volunteers at the Miami Veterans Affairs Medical Center and population based subjects living in largely Hispanic Hialeah, Florida.
Reliability estimates were calculated with kappa coefficients for categorical data and intraclass correlation coefficients for quantitative data. (...)
Mots-clés Pascal : Hypertrophie, Bénin, Afrique, Prostate, Adénocarcinome, Evaluation, Qualité vie, Origine ethnique, Espagnol, Traduction, Questionnaire, Résultat, Homme, Appareil urinaire pathologie, Prostate pathologie, Appareil génital mâle pathologie, Tumeur maligne
Mots-clés Pascal anglais : Hypertrophy, Benin, Africa, Prostate, Adenocarcinoma, Evaluation, Quality of life, Ethnic origin, Spanish, Translating, Questionnaire, Result, Human, Urinary system disease, Prostate disease, Male genital diseases, Malignant tumor
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0408068
Code Inist : 002B30A01A2. Création : 19/12/1997.